Application of a synthetic analogue of leu-enkephalin (Dalargin) in alcohol withdrawal.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1327707.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The effects of 1 mg of a synthetic analogue of leu-enkephalin (Dalargin) injected intramuscular twice daily for 3 consecutive days were studied in 20 patients with alcohol withdrawal syndrome. The results suggest that the therapeutic effects of Dalargin in alcohol withdrawal syndrome are mainly connected with the changes in the dopamine-, serotonin-, GABA- and opioid-ergic neurotransmitters systems.
Medical subject headings
- Enkephalin, Leucine-2-Alanine
- Ethanol
- Substance Withdrawal Syndrome
- Sympatholytics